Cargando…
Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel
Despite the challenges of the pandemic, there has been substantial progress with coronavirus disease 2019 (COVID-19) therapies. Pivotal COVID-19 trials like SOLIDARITY, RECOVERY, and ACCT-1 were rapidly conducted and data disseminated to support effective therapies. However, critical shortcomings re...
Autores principales: | Bhimraj, Adarsh, Morgan, Rebecca L, Shumaker, Amy Hirsch, Baden, Lindsey, Chi-Chung Cheng, Vincent, Edwards, Kathryn M, Gandhi, Rajesh T, Gallagher, Jason C, Muller, William J, O’Horo, John C, Shoham, Shmuel, Wollins, Dana Swartzberg, Falck-Ytter, Yngve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574532/ https://www.ncbi.nlm.nih.gov/pubmed/34668008 http://dx.doi.org/10.1093/cid/ciab882 |
Ejemplares similares
-
Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords
por: Bhimraj, Adarsh, et al.
Publicado: (2021) -
Pharmacologic Treatment and Management of Coronavirus Disease 2019
por: Shumaker, Amy Hirsch, et al.
Publicado: (2022) -
Thyroid disease in the time of COVID-19
por: Dworakowska, Dorota, et al.
Publicado: (2020) -
COVID-19 is, in the end, an endothelial disease
por: Libby, Peter, et al.
Publicado: (2020) -
COVID-19, hydroxychloroquine and the importance of disease
progression
por: Budny, John A
Publicado: (2021)